Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Sirona Biochem Signs Agreement with Luxembourg-based CURE Intelligence for Social Media and Communications Support
Sirona Biochem Signs Agreement with Luxembourg-based CURE Intelligence for Social Media and Communications Support

 

Vancouver, CanadaDecember 15, 2020Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce that it has signed an agreement with Luxembourg-based

Halo Completes C$7 Million At-the-Market Offering of Common Shares
Halo Completes C$7 Million At-the-Market Offering of Common Shares

 

This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated September 16, 2020 to its short form base shelf prospectus dated

European Metals Commences Trading on NASDAQ International
European Metals Commences Trading on NASDAQ International

 

-          European Metals accepted to trade on the globally renowned US based NASDAQ International OTC program

-          Company will commence trading on NASDAQ International under the

Datametrex Awarded Two Contracts with Insurance Provider and Airport Authority
Datametrex Awarded Two Contracts with Insurance Provider and Airport Authority

 

Toronto, Canada, December 15, 2020 Datametrex AI Limited (the "Company" or "Datametrex") (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has been awarded two AI related co

BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application
BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application

December 15, 2020 – BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and commercialization of

NetCents Technology Completes Bank Compliance Review and Moves Towards Credit Card Launch in Early 2021
NetCents Technology Completes Bank Compliance Review and Moves Towards Credit Card Launch in Early 2021

VANCOUVER, B.C., December 15, 2020NetCents Technology Inc. ("NetCents" or the "Company") (CSE: NC / Frankfurt: 26N / OTCQB: NTTCF), a cryptocurrency payments company, would like to provide

Psyched Wellness Successfully Completes Extraction of A Legal Psychedelic Mushroom
Psyched Wellness Successfully Completes Extraction of A Legal Psychedelic Mushroom

Toronto, Ontario, December 15, 2020 – Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) (CSE:PSYC, OTCQB:DCNPF, FRANKFURT:5U9) (the “Company” or “Psyched”) a life sciences

Modern Meat Announces the Launch of the Modern Gyoza, Co-packing Facility, and Sellout for Holiday Bundle Pilot Program
Modern Meat Announces the Launch of the Modern Gyoza, Co-packing Facility, and Sellout for Holiday Bundle Pilot Program

 

December 15, 2020, Vancouver, BC - - Modern Meat Inc., (CSE: MEAT) (“Modern Meat”) or (the “Company) an award-winning plant-based food manufacturer, is pleased to announce the launch of its

Letter From the President & CEO of Blue Lagoon Resources
Letter From the President & CEO of Blue Lagoon Resources

 

Dear Shareholders and Investors,

 

Those of you who know me personally, know that most of my 35 plus years in business have been in private family businesses. In 2010, at the invitation of

Mountain Valley MD Holdings Announces Strategic Private Placement Offering of Units, Appointment of Advisor Board Members, and Proposed Debt Settlement
Mountain Valley MD Holdings Announces Strategic Private Placement Offering of Units, Appointment of Advisor Board Members, and Proposed Debt Settlement

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have

Zadar/XRApplied Provides Corporate Update
Zadar/XRApplied Provides Corporate Update
News Release - Update - Dec 14 2020 (01834152.DOC;1)

 

December 14, 2020 Vancouver, British Columbia. Zadar Ventures Ltd. (the “Company”) would like to take this opportunity to update its

Hunter Technology Agrees to Acquire FinFabrik
Hunter Technology Agrees to Acquire FinFabrik

 

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH US NEWSWIRES

 

VANCOUVER, BC – December 14, 2020 – Hunter Technology Corp. (TSX-V: HOC; OTCQB: HOILF; WKN: A2QEYH, FSE: RWPM, ISIN:

Kodiak Copper Strengthens Board with Addition of Kevin Tomlinson
Kodiak Copper Strengthens Board with Addition of Kevin Tomlinson

December 14, 2020 – Vancouver, British Columbia – Kodiak Copper Corp. (the "Company" or “Kodiak”) (TSX-V: KDK) is pleased to announce the appointment of Mr. Kevin Tomlinson, HBSc., MSc., to

New Wave: N2 Logics Acquires Bloom Botanics E-commerce Platform - One of Europe's Leading Nutraceuticals Online Superstore for CBD and Mushroom Blend Products
New Wave: N2 Logics Acquires Bloom Botanics E-commerce Platform - One of Europe's Leading Nutraceuticals Online Superstore for CBD and Mushroom Blend Products

TORONTO, December 14th, 2020, N2 Logics Inc. in a joint venture with New Wave Holdings Ltd. ‐ NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR, FWB: 0XM2, OTC: TRMNF) an

Gold Bull completes Sandman purchase from Newmont
Gold Bull completes Sandman purchase from Newmont

Vancouver, B.C., December 14, 2020

Gold Bull Resources Corp. (TSX-V: GBRC) (“Gold Bull” or the “Company”) is pleased to announce it has completed the Sandman Project (“Sandman”) purchase

Havn Life Sciences undertakes one of the first preclinical studies on psilocybin and the immune system
Havn Life Sciences undertakes one of the first preclinical studies on psilocybin and the immune system

This is one of the first studies to examine how psilocybin affects the immune system and is a required step to file an application with the Food and Drug Administration (FDA), for a Phase 1

Gratomic Approved for Trading on the OTCQB Venture Market
Gratomic Approved for Trading on the OTCQB Venture Market
Blank

 

 

TORONTO, ON / December 14, 2020 / Gratomic Inc. ("GRAT" or the "Company") (TSXV:GRAT)(FRANKFURT:CB81) (WKN:A143MR) (OTCQB: CBULF) wishes to announce that its common shares have been

NeutriSci's Contract Partner, Tabletz LLC, Provides Update on Product Launch in Japan
NeutriSci's Contract Partner, Tabletz LLC, Provides Update on Product Launch in Japan

Vancouver, British Columbia December 14, 2020 NeutriSci International Inc. (“NeutriSci” or the “Company”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9), an innovative technology company

Hanstone Gold Announces an Additional Listing on the Frankfurt Exchange, Trading Under the Symbol HGO, FSE
Hanstone Gold Announces an Additional Listing on the Frankfurt Exchange, Trading Under the Symbol HGO, FSE

Vancouver, BC, Canada, December 14, 2020, Hanstone Gold Corp. (TSX.V: HANS, & FSE: HGO) (“Hanstone” or the “Company”) is pleased to announce it has commenced trading on the Frankfurt Stock

MustGrow Appoints Impossible Foods Executive to Board
MustGrow Appoints Impossible Foods Executive to Board

SASKATOON, Saskatchewan, Canada, Dec. 14, 2020 MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FRA: 0C0) (the "Company", "MustGrow") is pleased to announce the appointment of Mr. David

True Leaf Completes Amalgamation
True Leaf Completes Amalgamation

Vernon, BC - December 14, 2020 - True Leaf Brands Inc. (CSE: MJ) (OTC Pink: TRLFD) (FSE: TLA) (“True Leaf” or the “Company”) today announced that further to the press release issued on

EMX Royalty Acquires Shares of Daura Capital Corp.
EMX Royalty Acquires Shares of Daura Capital Corp.
_

Vancouver, British Columbia, December 14, 2020 (NYSE American: EMX; TSX Venture: EMX) – EMX Royalty Corporation (the “Company” or “EMX”) is pleased to report it has acquired ownership of 1.2

Antisense Therapeutics Limited: European Commission grants Orphan Drug Designation for ATL1102 in DMD
Antisense Therapeutics Limited: European Commission grants Orphan Drug Designation for ATL1102 in DMD
_ December 2008

-          Orphan Drug Designation (ODD) granted by the Commission;

-          Market exclusivity for 10 years upon regulatory approval;

-          Additional 2 years of